A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3847-3851

  Hoffmann, Jens ^a   Schirner, Michael ^b   Menrad, Andreas ^b   Schneider, Martin R ^b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; HEMOGLOBIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER THERAPY; CIRCULATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR CELL CULTURE; VASCULARIZATION;

ALGINATES; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, LEWIS LUNG; CARCINOMA, RENAL CELL; CYCLOHEXANES; DEXTRANS; DRUG CARRIERS; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GLUCURONIC ACID; HEMOSTATICS; HEXURONIC ACIDS; KIDNEY NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, NUDE; MICROSPHERES; MOLECULAR WEIGHT; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SESQUITERPENES; TUMOR CELLS, CULTURED;

EID: 0030865849     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
2. Fidler, I. J., and Ellis, L. M. The implication of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
3. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
4. Rifkin, D. B., and Moscatelli, D. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol., 109: 1-6, 1989.
5. Burgess, W. H., and Maciag, T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem., 58: 575-606, 1989.
6. Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J., and Leung, D. W. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem., 47: 211-218, 1991.
7. Auerbach, W., and Auerbach, R. Angiogenesis inhibition: a review. Pharmacol. & Ther., 63: 265-311, 1994.
8. Auerbach, R., Auerbach, W., and Polakowski, I. Assays for angiogenesis: a review. Pharmacol. & Ther., 51: 1-11, 1991.
9. Plunkett, M. L., and Hailey, J. A. An in vivo quantitative angiogenesis model using tumor cells entrapped in alginate. Lab. Invest., 62: 510-517, 1990.
10. Vorlop, K. D., and Klein, J. New developments in the field of cell immobilization: formation of biocatalysts by ionotropic gelation. In: R. M. Lafferty (ed.), Enzyme Technology, pp. 219-235. Berlin: Springer Verlag, 1983.
11. Robertson, N. E., Discafani, C. M., Downs, E. C., Hailey, J. A., Sarre, O., Runkle, R. L. J., Popper, T. L., and Plunkett, M. L. A quantitative in vivo mouse model used to assay inhibitors of tumor-induced angiogenesis. Cancer Res., 51: 1339-1344, 1991.
12. Rao, L. V. M. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev., 11: 249-266, 1992.
13. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285: 1182-1186, 1971.
14. Tiedeken, J. J., and Rovainen, C. M. Fluorescent imaging in vivo of developing blood vessels on the optic tectum of xenopus laevis. Microvasc. Res., 41: 376-389, 1991.
15. Minnicozzi, M., Duran, W. N., Gleich, G. J., and Egan, R. W. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. J. Immunol., 153: 2664-2670, 1994.
16. Kowallik, P., Schulz, R., Guth, B. D., Schade, A., Paffhausen, W., Gross, R., and Heusch, G. Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation, 83: 974-982, 1991.
17. Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., and Folkman, J. Synthetic analogues of fumagillin that inhibit angiogenesis and supress tumour growth. Nature (Lond.), 348: 555-557, 1990.
18. Yamaoka, M., Yamamoto, T., Ikeyama, S., Sudo, K., and Fujita, T. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res., 53: 5233-5236, 1993.
19. Yamaoka, M., Yamamoto, T., Masaki, T., Ikeyama, S., Sudo, K., and Fujita, T. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Res., 53: 4262-4267, 1993.
20. Abe, J., Zhou, W., Takuwa, N., Taguchi, J., Kurokawa, K., Kumada, M., and Takuwa, Y. A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or proto-oncogene expression in vascular endothelial cells. Cancer Res., 54: 3407-3412, 1994.
21. 1 phase of the cell cycle. Cancer Res., 54: 2073-2076, 1994.